The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.
Sixty-seven oral and poster presentations were showcased at the 13th annual Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).
Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.
Eighty-four student-scientists presented projects during the Ninth Annual Buffalo Summer Research Conference, an interdisciplinary forum marking the culmination of their summer research in Buffalo.
Department of Neurology researchers are helping to shed light on the effects of using gadodiamide as an imaging linear contrast agent in multiple sclerosis (MS) patients.
Jessy J. Alexander, PhD, research professor of medicine in the Division of Nephrology, has received funding to study complement activation and its role in kidney disease.
The Hunter James Kelly Research Institute (HJKRI) has received more than $2 million in National Institutes of Health (NIH) funding, enabling researchers to pursue a new approach to Krabbe disease.
The Jacobs School of Medicine and Biomedical Sciences is among 72 sites nationwide that are recruiting patients for a 12-week, randomized, placebo-controlled drug trial for the first treatment designed to benefit patients with mild-to-moderate Lewy body dementia (LBD).
Import medical school events to your personal calendar. Customize by selecting different event categories and receive automatic reminders of the school events that matter most to you.
